Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6533484 | 0.76 | CHRNB2 (0.34) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL6530931 | 0.76 | GAA (0.38) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL906504 | 0.71 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| SCHEMBL10965978 | 0.69 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL2422039 | 0.69 | GAA (0.42) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL1169589 | 0.69 | — | — | |
| SCHEMBL11296604 | 0.69 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL10956440 | 0.69 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL7417993 | 0.69 | HTT (0.38) | CHRNB2CHRNA4CHRNA7GAAALPG | |
| SCHEMBL20566144 | 0.68 | CHRNB2 (0.32) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537190-B1 | LIQUID CRYSTAL DOPANTS | POLYDISPLAY ASA (NO) | 2007-11-07 | — | — | EP | claimed |
| US-20060091358-A1 | Liquid crystal dopants | POLYDISPLAY ASA (NO) | 2006-05-04 | — | — | US | claimed |
| US-5811241-A | ATTACHING N-PROTECTED ALPHA-AMINO ACID TO POLYMERIC SUPPORT; DEPROTECTING; REDUCTIVE ALKYLATION; BROMOACETYLATION; REACTING WITH PRIMARY AMINE; CYCLIZATION; CLEAVAGE; FOR SYNTHESIZING COMBINATORIAL LIBRARIES | CORTECH, INC. (US) | 1998-09-22 | — | — | US | claimed |
| WO-1997010222-A1 | METHOD FOR PREPARING PIPERAZINES | CORTECH, INC. (US) | 1997-03-20 | — | — | WO | claimed |
| US-20240141514-A1 | INTERFACE FOR CARBON OXIDE ELECTROLYZER BIPOLAR MEMBRANE | SUMITOMO MITSUI BANKING CORPORATION | 2024-05-02 | — | — | US | disclosed |
| US-20240133058-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR COx REDUCTION | SUMITOMO MITSUI BANKING CORPORATION | 2024-04-25 | — | — | US | disclosed |
| WO-2024081524-A2 | INTERFACE FOR CARBON OXIDE ELECTROLYZER BIPOLAR MEMBRANE | TWELVE BENEFIT CORPORATION (US) | 2024-04-18 | — | — | WO | disclosed |
| US-20230265568-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR COx REDUCTION | TWELVE BENEFIT CORP (US) | 2023-08-24 | — | — | US | disclosed |
| US-11680328-B2 | Membrane electrode assembly for COx reduction | TWELVE BENEFIT CORPORATION (US) | 2023-06-20 | — | — | US | disclosed |
| US-20210395908-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR COx REDUCTION | SUMITOMO MITSUI BANKING CORPORATION | 2021-12-23 | — | — | US | disclosed |
| US-20210207275-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR COx REDUCTION | SUMITOMO MITSUI BANKING CORPORATION | 2021-07-08 | — | — | US | disclosed |
| WO-2021108446-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR COX REDUCTION | Opus 12 Incorporated (US) | 2021-06-03 | — | — | WO | disclosed |
| WO-2001032264-A1 | ARYL OLEFINIC AZACYCLIC, AND ARYL ACETYLENIC AZACYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS INHIBITORS OF NICOTINIC CHOLINERGIC RECEPTORS | TARGACEPT, INC. (US) | 2001-05-10 | — | — | WO | disclosed |
| WO-2001017943-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| US-6166048-A | Pharmaceutical compositions for inhibition of cytokine production and secretion | TARGACEPT, INC. (US) | 2000-12-26 | — | — | US | disclosed |
| WO-2000075110-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | TARGACEPT, INC. (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000062767-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDINE OR PYRIMIDINE DERIVATES FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION | TARGACEPT, INC. (US) | 2000-10-26 | — | — | WO | disclosed |
| EP-1042274-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | R.J. REYNOLDS TOBACCO COMPANY (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-2000023418-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE | R.J. REYNOLDS TOBACCO COMPANY (US) | 2000-04-27 | — | — | WO | disclosed |
| EP-0115031-A1 | Ferrosilicate molecular sieve composition | UNION CARBIDE CORPORATION (US) | 1984-08-08 | — | — | EP | disclosed |